|
| Mean | Range |
|
| Age | 44 years | 26–63 years |
|
| Number | (%) |
|
| Gender | | |
| Females | 11 | (74%) |
| Males | 4 | (26%) |
| Diagnosis | | |
| Generalized anxiety disorder | 15 | (100%) |
| Comorbid social anxiety disorder | 4 | (26%) |
| Medications at time of enrollment | | |
| Selective serotonin re-uptake inhibitor (SSRI) | 15 | (100%) |
|